Page 18 - Program Updates News Today

At its regular meeting Monday, the Transylvania County Board of Education voted unanimously to approve grant applications for up to $50 million that, if approved, could be used to supplement

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. (Nasdaq:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as...

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today provided corporate updates and...

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today provided corporate updates and...

AUSTIN, Texas, March 8, 2022 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (Nasdaq:AGLE), a clinical-stage biotechnology company developing a new g...

NORWOOD, Mass., March 8, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. , an immunology company, today provided corporate updates and reported financial results for the fourth quarter... | March 8, 2022

Press release content from PR Newswire. The AP news staff was not involved in its creation.

03.03.2022 - Phase 3 ENHANCE program on track to report top-line COPD data in 2022 Conference call today at 9:00 a.m. EST / 2:00 p.m. GMT LONDON and RALEIGH, N.C., March 03, 2022 (GLOBE NEWSWIRE) - Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Accesswire. The AP news staff was not involved in its creation.